Stocks
Intra-Cellular Therapies (ITCI) P/FCF US GAAP (year values) |
|||||||||
| FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | LTM ? | CAGR 5 years ? | |||
| P/FCF | -9.71 | -16.4 | 0.00 | 0.00 | -117.2 | -185.0 | |||
| Changes by years, y/y, % | -34% | +68% | -100% | +51.4% | |||||
Intra-Cellular Therapies. P/FCF
Intra-Cellular Therapies. P/FCF, changes, %
Intra-Cellular Therapies (ITCI) P/FCF US GAAP (quarter values) |
||||||||
| FY2023Q4 | FY2024Q1 | FY2024Q2 | FY2024Q3 | FY2024Q4 | LTM ? | |||
| P/FCF | 0.00 | 0.00 | 0.00 | -123.0 | -117.2 | -185.0 | ||
| Changes by years, y/y, % | -100% | -100% | ||||||
| Changes by quarters, q/q, % | -5% | |||||||
